Dianthus Therapeutics, Inc. · NASDAQ:DNTH

Veness Adam M exercised options for 15,000 Dianthus Therapeutics, Inc. shares (Form 4)

Traded Aug 13, 2026 · Filed Aug 14, 2026

On Aug 13, 2026, Veness Adam M (SVP, General Counsel and Sec.) exercised options for 15,000 Dianthus Therapeutics, Inc. shares at US$18.17 for US$273K, leaving 15,000 shares. Filed Aug 14, 2026 (Form 4).

Options exercised
15,000 shares
Price
US$18.17
Value
US$273K
Holding after
15,000 shares
Trading plan
No
Role
SVP, General Counsel and Sec.

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 13, 2026Common StockOption exercise15,000US$18.1715,000Direct

Source

View original at SEC

Related